補(bǔ)體因子I(CFI)重組蛋白
Recombinant Complement Factor I (CFI)
CF-I; C3b-INA; FI; IF; KAF; Factor I; Konglutinogen-Activating Factor; C3b-Inactivator; C3B/C4B inactivator
- 編號RPB978Hu02
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細(xì)胞定位分泌
- 預(yù)測分子量54.3kDa
- 實(shí)際分子量54kDa(差異分析請參閱說明書)
- 片段與標(biāo)簽Leu28~Gly243 with N-terminal His and GST Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 80%
- 等電點(diǎn)7.5
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1032 ¥ 2580 ¥ 5160 ¥ 15480 ¥ 38700
- 欲了解實(shí)際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Figure . Gene Sequencing (extract)
-
Figure. SDS-PAGE
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPB978Hu02 | 補(bǔ)體因子I(CFI)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB978Hu01 | 補(bǔ)體因子I(CFI)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB978Hu01 | 補(bǔ)體因子I(CFI)多克隆抗體 | WB; IHC; ICC; IP. |
| PAB978Hu02 | 補(bǔ)體因子I(CFI)多克隆抗體 | WB; IHC; ICC; IP. |
| MAB978Hu22 | 補(bǔ)體因子I(CFI)單克隆抗體 | WB; IHC; ICC; IP. |
| WEB978Hu | 補(bǔ)體因子I(CFI)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,寬范圍) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SEB978Hu | 補(bǔ)體因子I(CFI)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB978Hu | 補(bǔ)體因子I(CFI)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| J Thromb Haemost | A case report of thrombotic microangiopathy without renal involvement carrying two novel mutations in complement-regulator genes [PubMed: 26613809] |
| Pediatr Int | Atypical hemolytic uremic syndrome: Korean pediatric series [PubMed: 25443527] |
| United States Patent Application? | NOVEL ASSAY [y2016:139118] |
| Researchgate | Compliment factor i bioassay [US20170285024] |
| PLoS One | A monoclonal antibody targeting amyloid β (Aβ) restores complement factor I bioactivity: Potential implications in age-related macular degeneration and?… [Pubmed:29782502] |
| JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | The importance of sialic acid, pH and ion concentration on the interaction of uromodulin and complement factor H [33788378] |
留言咨詢
